共 39 条
- [31] Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09): : 4186 - 4192
- [33] A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clorniphene citrate for poor responders and women over 35 years FERTILITY AND STERILITY, 2004, 81 (06) : 1572 - 1577
- [34] A preliminary study on reduced dose (33 or 25 μg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (04) : 227 - 231
- [35] Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 381 - 397
- [38] Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (06) : 335 - 340
- [39] Comparison of the Recombinant Versus Highly-Purified, Urinary Follicle-Stimulating Hormone (r-FSH vs. HP-uFSH) in the Polycystic Ovary Syndrom Patients who had Antagonist Cycle with In Vitro Fertilization-Embryo Transfer TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (04): : 775 - 779